Skip to content

0 CyberKnife Treatment packages match your search

Compare clinics offering CyberKnife Treatment, with itemised packages. Video consultation with the clinic's medical team before you decide.

FiltersCyberKnife Treatment
Filters
CyberKnife Treatment

0 packages

No CyberKnife Treatment packages yet

Clinics add packages regularly. Set a price alert below and we will email you when the first one is listed.

Set a price alert
We'll email you when a CyberKnife Treatment drops below your target.

Email me price updates for this treatment. Unsubscribe any time. Privacy Policy

CyberKnife Treatment — what you should know in 2026

A plain-English guide to CyberKnife robotic stereotactic radiosurgery: how it works, which tumours it suits, what it costs abroad, and safe continuity of care.

Written by our medical board, reviewed quarterlyUpdated 21 January 19709 min read

What CyberKnife is and who it is for

CyberKnife is a brand of robotic stereotactic radiosurgery and stereotactic body radiotherapy. Despite the name, there is no knife and no incision: a robotic arm delivers many finely shaped beams of radiation from different angles that converge on the tumour with high precision, sparing surrounding tissue. Its distinctive feature is real-time image tracking that follows the target as you breathe, allowing it to treat moving tumours, such as some in the lung, liver or pancreas, as well as targets in the brain and spine.

It is used for small, well-defined tumours and for some metastases, either as a primary treatment when surgery is unsuitable or as a focused boost. It is not a treatment for widespread disease, and it is not a substitute for the systemic therapies that treat cancer throughout the body. A radiation oncologist decides whether your tumour's size, location and number make you a candidate, within a multidisciplinary plan.

Patients travel for CyberKnife partly because it is not available everywhere and partly because it is delivered in just a few sessions, which fits a focused trip better than weeks of daily radiotherapy. Even so, the wider cancer plan should stay connected to your home team.

How CyberKnife compares to other options

Compared with conventional radiotherapy, CyberKnife concentrates a very high dose into one to five sessions rather than spreading smaller doses over weeks, which is possible because of its extreme targeting accuracy. Compared with Gamma Knife — another stereotactic platform covered separately — CyberKnife is frameless (no rigid head frame is fixed to the skull) and can treat targets throughout the body, not only the head, whereas Gamma Knife is highly specialised for intracranial targets.

Compared with surgery, CyberKnife is non-invasive, requires no general anaesthetic and has no incision or surgical recovery, which makes it attractive for tumours that are hard to reach or in patients unfit for an operation. But it does not remove the tumour or provide tissue for the pathologist; it controls the tumour with radiation over time.

Which platform or approach is right is a clinical judgement based on the tumour, not a brand preference. A reputable centre explains why it is recommending CyberKnife over the alternatives for your particular case.

What is included and what it costs

A CyberKnife quote should cover the planning phase — a high-resolution planning CT, often fused with MRI or PET, target contouring, the dose plan and physics checks — plus the treatment sessions themselves and follow-up imaging to assess response. Because the platform is technologically intensive, planning is a substantial part of the work and the cost.

As a broad orientation only, a course of CyberKnife at an accredited international centre commonly falls in the mid-thousands of euros, with the total influenced by the number of sessions and the complexity of the target. Because it is delivered in so few sessions, the per-course figure is more comparable across patients than open-ended treatments, but it should still be quoted specifically.

Ask what follow-up imaging is included, since response to radiosurgery is assessed over months, and how the centre will report results to your home team so that surveillance can continue locally.

Choosing a centre and a radiation oncologist

Stereotactic radiosurgery is unforgiving of error because it delivers a very high dose in few sessions, so the quality of planning, physics and quality assurance is paramount. Look for hospital accreditation such as JCI, a board-certified radiation oncologist experienced specifically in stereotactic treatment, and a strong medical physics team. Ask how the centre verifies targeting and how often it treats tumours like yours.

Experience with your specific site matters: tracking a moving lung tumour is different from treating a fixed brain lesion. A centre that regularly treats your type of target, and can explain the dose and the organs it is protecting, is reassuring.

As with all radiation treatment, ensure the centre will provide a precise dose summary and share it, along with follow-up recommendations, with your home oncologist so that response can be monitored and any further treatment planned without gaps.

The procedure, recovery and follow-up

Treatment is typically delivered in one to five outpatient sessions, each lasting from around half an hour to an hour, during which you lie still while the robotic arm moves around you; there is no pain during treatment and no anaesthetic for most cases. Most people go home the same day and resume normal activities quickly, which is one of the main attractions of the approach.

Side effects are usually mild and depend on the area treated — some fatigue, or temporary local effects near the target. Because the tumour is controlled rather than removed, the response unfolds over weeks to months and is tracked with follow-up scans, so judging success is not immediate.

The short treatment makes a focused trip feasible, but follow-up imaging continues afterwards. Leave with your full dose and treatment record and a clear follow-up schedule, so your home team can carry out surveillance and act on the results.

Risks and what if something goes wrong

CyberKnife is non-invasive and generally well tolerated, but it is still high-dose radiation, so risks include inflammation or damage to healthy tissue near the target and, in the brain, effects such as swelling that may need treatment. As with all radiosurgery, accuracy is everything, which is why a centre's physics and quality systems matter far more than its price.

Because the tumour is not removed, there is also the possibility that it does not respond fully and that further treatment is needed; this is judged on follow-up imaging over months. That makes ongoing surveillance, and a home team equipped to provide it, essential after a treatment trip abroad.

Get a second opinion on whether radiosurgery is the right choice before committing, confirm how the centre handles any acute reaction, and ensure your dose record and follow-up plan reach your home oncologist. Keep every document, especially the dose summary.

Frequently asked

Is CyberKnife actually surgery?

No. Despite the name there is no incision or knife — it delivers highly focused radiation from a robotic arm. There is no anaesthetic for most cases and no surgical recovery.

How many sessions will I need?

Usually one to five outpatient sessions, depending on the tumour's size and location. This short course is one reason patients travel specifically for CyberKnife.

How is CyberKnife different from Gamma Knife?

Both are stereotactic radiosurgery, but CyberKnife is frameless and can treat targets throughout the body, including moving tumours, while Gamma Knife is highly specialised for fixed targets inside the head.

How much does CyberKnife cost abroad?

A course at an accredited international centre commonly falls in the mid-thousands of euros, influenced by the number of sessions and complexity. Ask for a quote that includes planning and follow-up imaging.

How soon will I know if it worked?

Not immediately. The tumour is controlled rather than removed, so the response unfolds over weeks to months and is assessed with follow-up scans, which should continue with your home team.

Is it suitable for any cancer?

No. CyberKnife suits small, well-defined tumours and some metastases, not widespread disease, and it does not replace systemic treatments. A radiation oncologist decides whether your case qualifies.